The latest research on risk factors and pathomechanisms of depression – review
DOI:
https://doi.org/10.12775/JEHS.2020.10.11.005Keywords
depression, SARS-CoV2, genetic, markers, inflammation, patomechanismAbstract
Introduction: Depression is a mental disorder that is increasingly being diagnosed in middle and more developed countries (MDC). Symptoms of depression in patients with severe depressive disorder (MDD) include sadness, regret, negative thoughts, anxiety, and more.
The aim of the study: The aim of the study was to summarize the latest research (from 2020) on factors related to the occurrence of depression, as well as the current findings on depression (also those related to the COVID-19 pandemic).
Material and method: For this purpose, scientific search engines such as PubMed and Google Scholar were used.
Description of the state of knowledge: In 2020, apart from research on pathomechanisms and environmental factors, a large part of the research focused on the COVID-19 pandemic as a risk factor for the development of depression symptoms. Many studies from different parts of the world have confirmed that a pandemic can have a significant impact on the occurrence of depression.
Summary: There are many factors that can cause depression and it is important to keep them in mind both in everyday life and in clinical practice. Studies from various parts of the world have shown that the COVID-19 pandemic has exacerbated the experience of depressive symptoms, also in those who have not yet been diagnosed with MDD. The degree of severity of depressive symptoms depended on such factors as: financial situation, social isolation.
References
Sprawka K, Wysokiński A, Orzechowska A, Talarowska-Bogusz M, Typel D, Gruszczyński W (2008) Zaburzenia depresyjne i lękowe w okresie klimakterium. Psychiatr 5:99–104.
Brown T., Melchior L., Huba G. Level of burden among women diagnosed with severe mental illness and substance abuse. J. Psychoactive Drugs 1999; 31: 31–41.
2. Ross BM. ω-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and genetically determined abnormality in phospholipid metabolism. Med Hypothes 2007; 68: 515–524.
Bujnowska-Fedak M, Grata-Borkowska U, Sapilak B. Otępienie i depresja u pacjentów w podeszłym wieku w Praktyce Lekarza Rodzinnego. Fam Med Prim Care Rev 2012; 14(3): 349–353.
Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Brit. J. Psychiatry 2004; 184: 386–392.
Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am. J. Psychiatry 1996; 153: 1411–1417.
Pużyński S. Depresje i samobójstwa. W: Pużyński S. red. Depresje i zaburzenia afektywne. Warszawa: Wydawnictwo Lekarskie PZWL; 2005, s. 98–107.
Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci. 2011;34:1–9.
Zyss T. Nowe techniki stymulacji elektrycznej i magnetycznej w terapii depresji – porównanie z elektrowstrząsami i farmakoterapią. Psychiatria Polska 2010, tom XLIV, numer 6, strony 853–869.
Perzyński A. Poziom funkcjonowania i rozpoznania stawiane przez psychiatrów u pacjentów kierowanych do poradni zdrowia psychicznego przez lekarzy rodzinnych. Fam Med Prim Care Rev 2013; 15(3): 368–369.
Ross BM. ω-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and genetically determined abnormality in phospholipid metabolism. Med Hypothes 2007; 68: 515–524.
Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutr J 2008; 7: 2.
Harbottle L, Schonfelder N. Nutrition and depression: a review of the evidence. J Ment Health 2008; 17(6): 576–587.
America A, Milling LS. The efficacy of vitamins for reducing or preventing depression symptoms in healthy individuals: natural remedy or placebo? J Behav Med 2008; 31: 157–167.
Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutr J 2008; 7: 2.
Roberts SH, Bedson E, Hughes DA, et al. Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomized controlled trial. BMC Psychiatry 2007; 7: 65.
Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, Chen X, Chen Y, Yang L, Ran Y, Zhong X, Xu S, Song X, Liu L, Zheng P, Wang H, Xie P. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry. 2020 Jan 20. doi: 10.1038/s41380-020-0645-4. Epub ahead of print. PMID: 31959849.
Iob E, Kirschbaum C, Steptoe A. Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms. Mol Psychiatry. 2020 May;25(5):1130-1140. doi: 10.1038/s41380-019-0501-6. Epub 2019 Aug 21. PMID: 31435001; PMCID: PMC7192852.
Ting EY, Yang AC, Tsai SJ. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020 Mar 22;21(6):2194. doi: 10.3390/ijms21062194. PMID: 32235786; PMCID: PMC7139933.
Chan SY, Probert F, Radford-Smith DE, Hebert JC, Claridge TDW, Anthony DC, Burnet PWJ. Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites. Sci Rep. 2020 Oct 8;10(1):16857. doi: 10.1038/s41598-020-74008-w. PMID: 33033375; PMCID: PMC7545201.
Bastiaanssen TFS, Cussotto S, Claesson MJ, Clarke G, Dinan TG, Cryan JF. Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder. Harv Rev Psychiatry. 2020 Jan/Feb;28(1):26-39. doi: 10.1097/HRP.0000000000000243. PMID: 31913980; PMCID: PMC7012351.
Nicolaou M, Colpo M, Vermeulen E, Elstgeest LEM, Cabout M, Gibson-Smith D, Knuppel A, Sini G, Schoenaker DAJM, Mishra GD, Lok A, Penninx BWJH, Bandinelli S, Brunner EJ, Zwinderman AH, Brouwer IA, Visser M. Association of a priori dietary patterns with depressive symptoms: a harmonised meta-analysis of observational studies. Psychol Med. 2020 Aug;50(11):1872-1883. doi: 10.1017/S0033291719001958. Epub 2019 Aug 14. PMID: 31409435; PMCID: PMC7477372.
An K, Zhao H, Miao Y, Xu Q, Li YF, Ma YQ, Shi YM, Shen JW, Meng JJ, Yao YG, Zhang Z, Chen JT, Bao J, Zhang M, Xue T. A circadian rhythm-gated subcortical pathway for nighttime-light-induced depressive-like behaviors in mice. Nat Neurosci. 2020 Jul;23(7):869-880. doi: 10.1038/s41593-020-0640-8. Epub 2020 Jun 1. PMID: 32483349.
Rehman, U., Shahnawaz, M. G., Khan, N. H., Kharshiing, K. D., Khursheed, M., Gupta, K., . . . Uniyal, R. (2020). Depression, Anxiety and Stress Among Indians in Times of Covid-19 Lockdown. Community Mental Health Journal. doi:10.1007/s10597-020-00664-x
Islam, M. A., Barna, S. D., Raihan, H., Khan, M. N., & Hossain, M. T. (2020). Depression and anxiety among university students during the COVID-19 pandemic in Bangladesh: A web-based cross-sectional survey. Plos One, 15(8). doi:10.1371/journal.pone.0238162
Ettman, C. K., Abdalla, S. M., Cohen, G. H., Sampson, L., Vivier, P. M., & Galea, S. (2020). Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Network Open, 3(9). doi:10.1001/jamanetworkopen.2020.19686
Bäuerle, A., Teufel, M., Musche, V., Weismüller, B., Kohler, H., Hetkamp, M., . . . Skoda, E. (2020). Increased generalized anxiety, depression and distress during the COVID-19 pandemic: A cross-sectional study in Germany. Journal of Public Health. doi:10.1093/pubmed/fdaa106
Sahu, P. (2020). Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on Education and Mental Health of Students and Academic Staff. Cureus. doi:10.7759/cureus.7541
Cao, W., Fang, Z., Hou, G., Han, M., Xu, X., Dong, J., & Zheng, J. (2020). The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry Research, 287, 112934. doi:10.1016/j.psychres.2020.112934
Law, T. (2020, April 17). Medical workers fighting COVID-19 are facing a mental health crisis. https://time.com/5817435/covid-19-mental-health-coronavirus/
Alim S, Rabbani M, Karim E, Mullick M, Al Mamun A, Khan M. Assessment of depression, anxiety and stress among first year MBBS students of a public medical college, Bangladesh. Bangladesh Journal of Psychiatry. 2015;29(1):23–9.
Mamun MA, Hossain MS, Griffiths MD. Mental health problems and associated predictors among Bangladeshi students. International Journal of Mental Health and Addiction. 2019.
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population. Medical Care, 46(3), 266-274. doi:10.1097/mlr.0b013e318160d093
Hinz, A., Klein, A. M., Brähler, E., Glaesmer, H., Luck, T., Riedel-Heller, S. G., . . . Hilbert, A. (2017). Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. Journal of Affective Disorders, 210, 338-344. doi:10.1016/j.jad.2016.12.012
Mazza, M. G., Lorenzo, R. D., Conte, C., Poletti, S., Vai, B., Bollettini, I., . . . Benedetti, F. (2020). Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity, 89, 594-600. doi:10.1016/j.bbi.2020.07.037
Tang, F., Liang, J., Zhang, H., Kelifa, M. M., He, Q., & Wang, P. (2020). COVID-19 related depression and anxiety among quarantined respondents. Psychology & Health, 1-15. doi:10.1080/08870446.2020.1782410
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 593
Number of citations: 0
